ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Pomalidomid-Teva Mepha 3 mg, Hartkapseln - 21
69497006 Teva Pharma AG
Pomalidomid-Teva Mepha 3 mg, Hartkapseln11.10.2024
  11.10.2024
Pomalidomide (L04AX06) 
WHO-DDD10.10.2029
21
07.16.40. 
A  
No 
IP 
PR  
k.A.PR
  
7680694970068Synthetika
  
Composition
pomalidomidum 3 mg, isomaltum 75.3 mg, amylum pregelificatum, natrii stearylis fumaras, Kapselhülle: gelatina, aqua purificata, E 133, E 171, Drucktinte: lacca, ammoniae solutio concentrata, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.05 mg.
Packungsbestandteile
Capsules
 
 
Active AgentDose
Pomalidomidum3 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
Ammoniae Solutio Concentrata  
Amylum Pregelificatum  
Aqua Purificata  
E 133 color.
E 171 color.
E 172 color.
Gelatina Kapselhülle
Isomaltum75.3 mg 
Kalii Hydroxidum  
Lacca Drucktinte
Natrii Stearylis Fumaras  
Source
Data was imported : 06.11.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home